XML 20 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net income $ 69,371,000 $ 6,330,000
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 13,359,000 15,923,000
Amortization and impairment of intangible assets 3,669,000 3,817,000
Provision for loan and lease losses 63,542,000 138,412,000
Deferred income tax expense (benefit) 19,153,000 (102,000)
Stock-based compensation 5,132,000 4,535,000
Gain on sales of investments (6,104,000) 0
Gain on early extinguishment of debt (4,217,000) 0
Other-than-temporary impairments on debt securities [1] 6,687,000 13,484,000
Unrealized loss (gain) on derivative instruments 19,000 (47,000)
Net gain on disposition of premises and equipment and other assets (686,000) (137,000)
Net gain on sales of loans (7,794,000) (5,312,000)
Net amortization/accretion of premiums, discounts and deferred loan fees and costs (6,629,000) (4,244,000)
Originations and purchases of loans held for sale (354,006,000) (323,565,000)
Sales and repayments of loans held for sale 355,636,000 329,635,000
Amortization of broker placement fees 2,300,000 3,564,000
Net amortization/accretion of premium and discounts on investment securities 4,503,000 6,431,000
Decrease in accrued interest receivable 7,258,000 3,894,000
(Decrease) increase in accrued interest payable (27,865,000) 3,297,000
(Increase) decrease in other assets (10,275,000) 8,478,000
(Decrease) increase in other liabilities (13,944,000) 8,175,000
Bargain purchase gain 0 (13,443,000)
Net cash provided by operating activities 119,109,000 199,125,000
Cash flows from investing activities:    
Principal collected on loans 2,174,933,000 2,223,880,000
Loans originated and purchased (2,085,444,000) (2,180,333,000)
Proceeds from sale of loans held for investment 20,186,000 107,702,000
Proceeds from sale of repossessed assets 43,093,000 48,195,000
Proceeds from sale of available-for-sale securities 219,780,000 0
Purchases of available-for-sale securities (420,513,000) (161,366,000)
Purchases of securities held to maturity 0 4,530,000
Proceeds from principal repayments and maturities of available-for-sale securities 270,345,000 212,972,000
Proceeds from principal repayments and maturities of held-to-maturity securities 5,293,000 5,068,000
Additions to premises and equipment (8,239,000) (9,594,000)
Proceeds from sale of premises and equipment and other assets 2,265,000 2,511,000
Net cash received from acquisition 0 217,659,000
Net cash outflows from purchase/sale of insurance contracts (960,000) 0
Net redemptions (purchases) of other equity securities (3,452,000) 567,000
Net cash provided by investing activities 224,191,000 461,597,000
Cash flows from financing activities:    
Net decrease in deposits (358,930,000) (294,126,000)
Repayment of FHLB advances (100,000,000) 0
Repurchase of outstanding common stock (860,000) (967,000)
Change in securities sold under agreements to repurchase (100,000,000) (200,000,000)
Repayment of junior subordinated debentures (7,025,000) 0
Net cash used in financing activities (566,815,000) (495,093,000)
Net (decrease) increase in cash and cash equivalents (223,515,000) 165,629,000
Cash and cash equivalents at beginning of period 752,458,000 796,108,000
Cash and cash equivalents at end of period 528,943,000 961,737,000
Cash and cash equivalents include:    
Cash and Cash Equivalents, at Carrying Value, Total $ 752,458,000 $ 796,108,000
[1] For the nine-month periods ended September 30, 2016 and 2015, approximately $6.3 million and $12.9 million, respectively, of the credit impairment recognized in earnings consisted of credit losses on Puerto Rico Government debt securities and $0.4 million and $0.6 million, respectively, was associated with credit losses on private label MBS.